title: SK & F 96365 inhibits carbachol-induced phosphoinositide turnover in human neuroblastoma SH-SY5Y and rat cerebellar granule cells.
abstract: SK & F 96365, a receptor-mediated Ca2+ entry inhibitor, has been reported to inhibit Ca2+ responses to various agonists without affecting internal Ca2+ release and phosphoinositide turnover. Since muscarinic acetylcholine receptor-mediated phosphoinositide turnover shows a marked dependence on factors affecting cytosolic Ca2+ concentration, the effects of SK & F 96365 on the coupling of muscarinic receptors to the phosphoinositide hydrolysis were examined in human neuroblastoma SH-SY5Y and rat cerebellar granule cells. SK & F 96365 concentration-dependently (3-30 microM) inhibited the inositol phosphate formation elicited by carbachol in both cellular systems. Moreover, SK & F 96365 inhibited the carbachol-induced inositol phosphate formation in the absence of extracellular Ca2+, and similar extent of inhibition was achieved in the presence or absence of extracellular Ca2+. In ligand binding studies, we found that the binding affinities for [3H] N-methyl-scopolamine in both cells were attenuated by SK & F 96365 (3-30 microM), while Bmax values for the ligand were not changed. The competition curves of SK & F 96365 showed a Ki value of 28.4 uM in SH-SY5Y cells. The results indicated that the decrease of carbachol-stimulated phosphoinositide hydrolysis by SK & F 96365 is due to the competitive inhibition of agonist binding to the M3 muscarinic receptors.
authors.affiliation: Department of Pharmacology, College of Medicine, National Taiwan University, Taipei.
authors.forename: W W
authors.initials: WW
authors.lastname: Lin
authors.forename: C W
authors.initials: CW
authors.lastname: Wang
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002217:Carbachol / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D002478:Cells, Cultured; D002531:Cerebellum / Q000378:metabolism; D003594:Cytoplasmic Granules / Q000378:metabolism; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D019832:N-Methylscopolamine; D009447:Neuroblastoma / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism*; D011869:Radioligand Assay; D051381:Rats; D012602:Scopolamine Derivatives / Q000378:metabolism; D014316:Tritium; D014407:Tumor Cells, Cultured
chemical_list: D002121:Calcium Channel Blockers; D007093:Imidazoles; D010716:Phosphatidylinositols; D012602:Scopolamine Derivatives; D014316:Tritium; D002217:Carbachol; C063159:1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole; D019832:N-Methylscopolamine